These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1604577

  • 1. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G, Zhong R, Zhang Z, Garcia B, Black R, Duff J, Grant D.
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract] [Full Text] [Related]

  • 2. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H, Wu J, Xu D, Aboujaoude M, Stepkowski S, Kahan B, Daloze P.
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
    Chen H, Wu J, Xu D, Luo H, Daloze P.
    Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H, Wu J, Luo H, Daloze P.
    Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
    [No Abstract] [Full Text] [Related]

  • 7. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
    Chen H, Xu D, Qi S, Wu J, Luo H, Daloze P.
    Transplantation; 1995 Apr 27; 59(8):1084-9. PubMed ID: 7732551
    [Abstract] [Full Text] [Related]

  • 8. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF, Wu JP, Luo HY, Daloze PM.
    Transplant Proc; 1991 Aug 27; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C, Heemann U, Azuma H, Tilney NL.
    Transplant Proc; 1995 Feb 27; 27(1):438-9. PubMed ID: 7879053
    [No Abstract] [Full Text] [Related]

  • 11. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H, Wu J, Xu D, Luo H, Daloze P.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract] [Full Text] [Related]

  • 12. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
    Tucker MJ, Duplan J, Li X, Garcia B, Wijsman J, Stiller C, McKenzie FN.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):725-6. PubMed ID: 8438458
    [No Abstract] [Full Text] [Related]

  • 13. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1991 Dec 27; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract] [Full Text] [Related]

  • 14. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G, Hancock WW, Wasowska B, Binder J, Padberg W, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 27; 27(1):427-9. PubMed ID: 7879048
    [No Abstract] [Full Text] [Related]

  • 15. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF, Xiao F, Kociss K, Chong AS, Sankary HN, McChesney L, Cohn S, Williams JW.
    Transplant Proc; 1994 Jun 27; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract] [Full Text] [Related]

  • 16. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T, Stepkowski SM, Smith S, Kahan BD.
    Transplant Proc; 1994 Oct 27; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract] [Full Text] [Related]

  • 17. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B, Wieder KJ, Hancock WW, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 27; 27(1):423-6. PubMed ID: 7879047
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
    Hamashima T, Yoshimura N, Ohsaka Y, Oka T, Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):723-4. PubMed ID: 8438457
    [No Abstract] [Full Text] [Related]

  • 20. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection.
    Thompson P, Xu D, Brunette I, Chen H.
    Transplant Proc; 1998 Jun 27; 30(4):1033-5. PubMed ID: 9636417
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.